How to Diagnose and Treat Breast Implant–Associated Anaplastic Large Cell Lymphoma

Plastic and Reconstructive Surgery - Tập 141 Số 4 - Trang 586e-599e - 2018
Mark W. Clemens1,2,3, Garry S. Brody1,2,3, Raman C. Mahabir1,2,3, Roberto N. Miranda1,2,3
1Ariz.
2Calif
3Texas

Tóm tắt

Learning Objectives: After reading this article, the participant should be able to: 1. Describe the diagnostic criteria for breast implant–associated (BIA) anaplastic large cell lymphoma (ALCL). 2. Appropriately evaluate a patient with suspected BIA-ALCL, including appropriate imaging, laboratory tests, and pathologic evaluation. 3. Understand the operative treatment of BIA-ALCL, and indications for systemic chemotherapy and/or radiation therapy in advanced disease. 4. Understand treatment outcomes and prognosis based on stage of disease. Summary: The goal of this continuing medical education module is to present the assessment of a patient with suspected breast implant–associated anaplastic large cell lymphoma, the evaluation and diagnosis, the preoperative oncologic workup, the formation and execution of a surgical treatment plan, and the inclusion of adjunct treatments when indicated. In addition, staging and disease progression for treatment of breast implant–associated anaplastic large cell lymphoma are discussed.

Từ khóa


Tài liệu tham khảo

Clemens, 2015, Coming of age: Breast implant-associated anaplastic large cell lymphoma after 18 years of investigation., Clin Plast Surg, 42, 605, 10.1016/j.cps.2015.06.006

Ramos-Gallardo, 2016, Breast implant and anaplastic large cell lymphoma meta-analysis., J Invest Surg, 18, 1

Gidengil, 2015, Breast implant-associated anaplastic large cell lymphoma: A systematic review., Plast Reconstr Surg, 135, 713, 10.1097/PRS.0000000000001037

Clemens, 2017, Understanding rare adverse sequelae of breast implants: Anaplastic large-cell lymphoma, late seromas, and double capsules., Gland Surg, 6, 169, 10.21037/gs.2016.11.03

Swerdlow, 2016, The 2016 revision of the World Health Organization classification of lymphoid neoplasms., Blood, 127, 2375, 10.1182/blood-2016-01-643569

Hu, 2015, Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: Implications for breast implant-associated lymphoma., Plast Reconstr Surg, 135, 319, 10.1097/PRS.0000000000000886

Jacombs, 2014, In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants., Plast Reconstr Surg, 133, 471e, 10.1097/PRS.0000000000000020

Hammond, 2015, Reply: Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: Implications for breast implant–associated lymphoma., Plast Reconstr Surg, 135, 1057e, 10.1097/PRS.0000000000001254

Prince, 2016, Commentary on: Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma., Aesthet Surg J, 36, 782, 10.1093/asj/sjw065

Kadin, 2016, Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma., Aesthet Surg J, 36, 773, 10.1093/asj/sjw023

Brody, 2016, The case against biofilm as the primary initiator of breast implant-associated anaplastic large cell lymphoma., Plast Reconstr Surg, 137, 766e, 10.1097/01.prs.0000480003.80422.03

Bizjak, 2015, Silicone implants and lymphoma: The role of inflammation., J Autoimmun, 65, 64, 10.1016/j.jaut.2015.08.009

Orciani, 2016, MSCs and inflammation: New insights into the potential association between ALCL and breast implants., Breast Cancer Res Treat, 156, 65, 10.1007/s10549-016-3745-8

Miranda, 2014, Breast implant-associated anaplastic large-cell lymphoma: Long-term follow-up of 60 patients., J Clin Oncol, 32, 114, 10.1200/JCO.2013.52.7911

Lechner, 2012, Survival signals and targets for therapy in breast implant-associated ALK–anaplastic large cell lymphoma., Clin Cancer Res, 18, 4549, 10.1158/1078-0432.CCR-12-0101

Montgomery-Goecker, 2015, Immunophenotypic characteristics of breast implant-associated anaplastic large-cell lymphoma by flow cytometry., Cytometry B Clin Cytom, 88, 291, 10.1002/cyto.b.21222

Kuehlmann, 2016, Breast implants and possible association with ALCL: A retrospective study including a histological analysis of 296 explanted breast tissues and current literature., Clin Hemorheol Microcirc, 63, 439, 10.3233/CH-162071

Taylor, 2013, Anaplastic large cell lymphoma occurring in association with breast implants: Review of pathologic and immunohistochemical features in 103 cases., Appl Immunohistochem Mol Morphol, 21, 13, 10.1097/PAI.0b013e318266476c

Xu, 2014, Breast implant-associated anaplastic large cell lymphoma: Review of a distinct clinicopathologic entity., Arch Pathol Lab Med, 138, 842, 10.5858/arpa.2013-0068-RS

Miranda, 2009, Anaplastic large cell lymphoma involving the breast: A clinicopathologic study of 6 cases and review of the literature., Arch Pathol Lab Med, 133, 1383, 10.5858/133.9.1383

Aladily, 2012, Breast implant-associated anaplastic large cell lymphoma: A newly recognized entity that needs further refinement of its definition., Leuk Lymphoma, 53, 749, 10.3109/10428194.2011.639020

Aladily, 2012, Anaplastic large cell lymphoma associated with breast implants: A report of 13 cases., Am J Surg Pathol, 36, 1000, 10.1097/PAS.0b013e31825749b1

de Jong, 2008, Anaplastic large-cell lymphoma in women with breast implants., JAMA, 300, 2030, 10.1001/jama.2008.585

Doren, 2017, U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma., Plast Reconstr Surg, 139, 1042, 10.1097/PRS.0000000000003282

Srinivasa, 2017, Global adverse event reports of breast implant-associated ALCL: An international review of 40 government authority databases., Plast Reconstr Surg, 139, 1029, 10.1097/PRS.0000000000003233

Loch-Wilkinson, 2017, Breast implant associated anaplastic large cell lymphoma in Australia and New Zealand: High surface area textured implants are associated with increased risk., Plast Reconstr Surg, 140, 1029, 10.1097/PRS.0000000000003654

Campanale, 2018, 22 Cases of breast implant-associated ALCL: Awareness and outcome Tracking from the Italian ministry of health., Plast Reconstr Surg, 141:11e–19e

Adrada, 2014, Breast implant-associated anaplastic large cell lymphoma: Sensitivity, specificity, and findings of imaging studies in 44 patients., Breast Cancer Res Treat, 147, 1, 10.1007/s10549-014-3034-3

Acevedo-Báñez, 2015, 18F-FDG-PET/CT in implant-associated anaplastic large cell lymphoma of the breast., Br J Haematol, 169, 1, 10.1111/bjh.13268

Clemens, 2016, Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma., J Clin Oncol, 34, 160, 10.1200/JCO.2015.63.3412

Brody, 2015, Anaplastic large cell lymphoma occurring in women with breast implants: Analysis of 173 cases., Plast Reconstr Surg, 135, 695, 10.1097/PRS.0000000000001033

Clemens, 2016, Breast implant informed consent should include the risk of anaplastic large cell lymphoma., Plast Reconstr Surg, 137, 1117, 10.1097/01.prs.0000481103.45976.b1

Clemens, 2017, NCCN Consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma., Aesthet Surg J, 37, 285, 10.1093/asj/sjw259

McGuire, 2017, Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants., Plast Reconstr Surg, 139, 1, 10.1097/PRS.0000000000002837

Di Napoli, 2017, Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma., PLoS One, 12, e0181097, 10.1371/journal.pone.0181097

Alcalá, 2016, Skin involvement as the first manifestation of breast implant-associated anaplastic large cell lymphoma., J Cutan Pathol, 43, 602, 10.1111/cup.12697

Lazzeri, 2012, Capsular contracture as a further presenting symptom of implant-related anaplastic large cell lymphoma., Am J Surg Pathol, 36, 1735, 10.1097/PAS.0b013e318267b048

de Boer, 2018, Breast implants and the risk of anaplastic large-cell lymphoma in the breast., JAMA Oncol, 10.1001/jamaoncol.2017.4510

Clemens, 2015, Commentary on: Lymphomas associated with breast implants: A review of the literature., Aesthet Surg J, 35, 545, 10.1093/asj/sjv056

Falini, 1995, CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy., Blood, 85, 1, 10.1182/blood.V85.1.1.bloodjournal8511

Cheson, 2014, Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification., J Clin Oncol, 32, 3059, 10.1200/JCO.2013.54.8800

Paulli, 1995, CD30/Ki-1-positive lymphoproliferative disorders of the skin: Clinicopathologic correlation and statistical analysis of 86 cases. A multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group., J Clin Oncol, 13, 1343, 10.1200/JCO.1995.13.6.1343

Wieser, 2016, Lymphomatoid papulosis in children and adolescents: A systematic review., Am J Clin Dermatol, 17, 319, 10.1007/s40257-016-0192-6

Clemens, 2015, Characteristics and treatment of patients with breast implant-associated anaplastic large cell lymphoma presenting with aggressive features., Plast Reconstr Surg, 136, 119, 10.1097/01.prs.0000472428.27422.0d

Brody, 2012, Brief recommendations for dealing with a new case of anaplastic large T-cell lymphoma., Plast Reconstr Surg, 129, 871e, 10.1097/PRS.0b013e31824a9e6d

Horwitz, 2016, NCCN guidelines insights: Non-Hodgkin’s lymphomas, version 3.2016., J Natl Compr Canc Netw, 14, 1067, 10.6004/jnccn.2016.0117

Pro, 2014, Four-year survival data from an ongoing pivotal phase 2 study of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma., Blood, 124, 3095, 10.1182/blood.V124.21.3095.3095

Pro, 2012, Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: Results of a phase II study., J Clin Oncol, 30, 2190, 10.1200/JCO.2011.38.0402

Zimmerman, 2015, Recurrent systemic anaplastic lymphoma kinase-negative anaplastic large cell lymphoma presenting as a breast implant-associated lesion., Cancer Control, 22, 369, 10.1177/107327481502200317

Johnson, 2017, Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): The UK experience and first reported case of neoadjuvant brentuximab., Cancer Res, 77, Abstract P50302, 10.1158/1538-7445.SABCS16-P5-03-02

Richardson, 2017, Breast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature., Molecular and Clinical Oncology, 6, 539, 10.3892/mco.2017.1170

Khosravi, 2016, Metastatic melanoma with spontaneous complete regression of a thick primary lesion., JAAD Case Reports, 2, 439, 10.1016/j.jdcr.2016.09.011

Carty, 2011, A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast., Plast Reconstr Surg, 128, 112e, 10.1097/PRS.0b013e318221db96

Ivaldi, 2013, Two cases of lymphoma in an implant capsule: A difficult diagnosis, an unknown pathology (in French)., Ann Chir Plast Esthet, 58, 688, 10.1016/j.anplas.2013.04.003

Keech, 1997, Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant., Plast Reconstr Surg, 100, 554, 10.1097/00006534-199708000-00065

Thông tin
Thông tin xuất bản

Plastic and Reconstructive Surgery

Tập 141 Số 4

586e-599e

Thông tin tác giả